Sēon Diagnostics is an early-stage company creating a suite of medical software products to automatically detect disease in medical images, freeing up physician time to focus on patient care and reducing the escalating cost of image analysis.

Our first product, SēonDx-Retina, identifies diabetic retinopathy, a disease of the light sensitive membrane at the back of the eye, caused by diabetes. Identified early, diabetic retinopathy is eminently treatable. However, millions of people around the world who are living with diabetes have no access to routine eye screening and are therefore at risk of sight impairment or even blindness as a consequence.

SēonDx-Retina has the potential to make routine eye screening available to everyone who needs it, anywhere in the world.

The platform technology that underpins SēonDx-Retina has the potential to help physicians caring for patients living with other chronic diseases and where medical images are central to their management, for example, in cancer, cardiac and neurological diseases.

We are seeking potential investors with experience of investing in medical technology businesses to support our next funding round – if you are interested, please contact info@seondx.com to learn more.

Contact us by email: info@seondx.com